AHT.F Ashland Inc.
- Market cap
- EUR 3.11B
- P/E
- 144.7x
- P/B
- 1.90x
- ROE
- 1.4%
- Dividend yield
- 2.14%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.
Is AHT.F undervalued?
Graham numberThe Graham number of Ashland Inc. cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ashland Inc. fundamental analysis
No fundamental analysis for Ashland Inc. yet.
Ashland Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ashland Inc.
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, …
Full company profileAshland Inc. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ashland Inc. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 2.39B | 2.19B | 2.11B | 1.82B | 1.82B |
| Gross Profit | 830M | 668M | 618M | 549M | 563M |
| Operating Income | 288M | 159M | 83.0M | 88.0M | 94.7M |
| EBITDA | 509M | 457M | 303M | -511M | 331M |
| Net Income | 927M | 178M | 169M | -845M | 26.7M |
| EPS | 17 | 3.49 | 3.60 | -18 | 0.58 |
| Balance Sheet | |||||
| Total Assets | 6.21B | 5.94B | 5.65B | 4.61B | 4.58B |
| Total Liabilities | 2.99B | 2.84B | 2.78B | 2.71B | 2.71B |
| Shareholders' Equity | 3.22B | 3.10B | 2.87B | 1.90B | 1.87B |
| Cash & Short-term Investments | 646M | 417M | 300M | 215M | 440M |
| Cash Flow | |||||
| Operating Cash Flow | -213M | 243M | 411M | 94.0M | 352M |
| Capital Expenditure | 113M | 170M | 137M | 98.0M | 68.0M |
| Free Cash Flow | -326M | 73.0M | 274M | -4.00M | 284M |
| Ratios | |||||
| ROE | 28.8% | 5.7% | 5.9% | -44.4% | 1.4% |
| ROA | 14.9% | 3.0% | 3.0% | -18.3% | 0.6% |
| Net Profit Margin | 38.8% | 8.1% | 8.0% | -46.3% | 1.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Ashland Inc. dividends
- Dividend yield
- 2.14%
- Forward dividend
- 1.46 EUR
- Payout ratio
- -
- Ex-dividend date
- Sep 1, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 76.0M | 1.65 | - |
| 2024 | USD 78.0M | 1.66 | 46.2% |
| 2023 | USD 76.0M | 1.49 | 42.7% |
| 2022 | USD 70.0M | 1.30 | 7.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Ashland Inc.
- Insiders 1.18%
- Institutions 98.82%
- Public & others 0.00%
- Shares outstanding 45.8M
- Free float 37.9M
Ashland Inc. company profile
- Company name
- Ashland Inc.
- Ticker
- AHT.F
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Employees
- 2,800
- Fiscal year end
- September
- Address
- 8145 Blazer Drive, Wilmington, DE, United States, 19808
- Phone
- 302 995 3000
- Website
- ashland.com
About Ashland Inc.
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
Ashland Inc. management
10- Mr. Guillermo NovoChairman & CEO · born 1962
- Mr. William C. Whitaker C.F.A.Senior VP, CFO & Director of Investor Relations · born 1989
- Dr. Osama M. Musa Ph.D.Senior VP & CTO · born 1968
- Mr. James P. MinicucciSenior VP & GM of Personal Care · born 1982
- Ms. Alessandra Faccin AssisSenior VP and GM of Life Sciences & Intermediates · born 1980
- Mr. Wayne MuilSenior Vice President of Operations
- Mr. Samuel A. RichardsonVP, Controller & Principal Accounting Officer · born 1979
- Ms. Robin E. LampkinSenior VP, General Counsel & Secretary · born 1963
- Carolmarie C. BrownVice President of Corporate Affairs, Global Marketing, Brand & Business Communications
- Ms. Eileen M. DrurySenior VP & Chief HR Officer · born 1968